AVI BioPharma (AVII) Elevated May option implied volatility stays high at 148

April 19, 2006 2:17 PM EDT Send to a Friend
AVI BioPharma (NASDAQ: AVII) : AVII develops therapeutic products for the treatment of life-threatening diseases using ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login